The High Intensity Focused Ultrasound (HIFU) Market, estimated at USD 129.8 Mn in 2025, is expected to exhibit a CAGR of 7.16% and reach USD 210.6 Mn by 2032.
The industry is witnessing significant growth driven by rising demand for advanced, reliable, and cost-effective medical devices across diagnostic, therapeutic, and monitoring applications. Rapid advancements in device design, digital health integration, and adoption of minimally invasive technologies are reshaping the competitive landscape. Furthermore, supportive regulatory frameworks, increasing healthcare investments, and the growing focus on patient-centric care are expected to create new growth avenues for market players.
Increasing number of cancer cases worldwide is expected to boost the market growth over forecast period. For instance, according to World Cancer Research Fund International, there were 18,094,716 new cases of cancer in 2025 worldwide. Among these, 7.8% were prostate cancer, 12.5% were breast cancer, and 10.7% were colorectal cancer, among other cancer types.
Global High Intensity Focused Ultrasound (HIFU) Market – Impact of Coronavirus (COVID-19) Pandemic
The World Health Organization (WHO) designated the illness caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that first appeared in Wuhan (province of Hubei, China) in the last months of 2025, as "coronavirus disease 2025," or COVID-19. This virus spreads quickly and had a serious negative impact on the economies, social behaviors, and health of every country in the world.
The COVID-19 had a negative impact on global high intensity focused ultrasound (HIFU) market, as dermatology clinic visits was decreased during the COVID-19 pandemic. For instance, according to data published by Dermatology Reports, in November 2025, the fear of COVID-19 infection and its rapid transmission have resulted in less frequent visits to crowded places such as dermatology clinics and hospitals. According to the same source in 2025, the number of cases of acne vulgaris became the second largest, but in 2025, the number of cases of acne vulgaris decreased to the fifth largest. These results support the finding that COVID-19, although not a skin disease, had impact on dermatology and outpatient clinic which resulted in low clinic visits.
Global High Intensity Focused Ultrasound (HIFU) Market: Key Developments
In August 2025, Verasonics, a company in the development of leading-edge ultrasound research technologies, and Sonic Concepts, Inc., a global company manufacturing ultrasonic transducers and systems, announced the collaboration to expand the HIFUPlex Portfolio to include full turnkey ultrasound-guided focused ultrasound solutions for preclinical research on both small and large subjects. HIFUPlex portfolio is designed to facilitate and advance FUS (Focused Ultrasound) research across a variety of clinical areas. The system brings together Verasonics’ Vantage platform and Sonic Concepts’ therapy and imaging transducers.
In March 2025, UMC Utrecht, a Hospital in Netherlands, initiated a study for noninvasive palliative pain treatment in patients with bone metastases using MR-HIFU procedure. The study is in phase 3 of clinical trials and is expected to complete in June 2025.